Reproductive history and risk of three breast cancer subtypes defined by three biomarkers

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Causes and Control

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10552-010-9709-0PMID 21184265PMCID PMC3042513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A case–control study of reproductive factors associated with subtypes of breast cancer in Northeast China

  2010cited by this paper
• Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.

  2010cited by this paper
• Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival

  2009influential reference
• Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer

  2009cited by this paper
• The epidemiology of triple-negative breast cancer, including race

  2009cited by this paper
• Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer

  2009cited by this paper
• Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years

  2009cited by this paper
• Epidemiology of basal-like breast cancer

  2008cited by this paper
• Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

  2008cited by this paper
• Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study

  2007influential reference
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

  2006influential reference
• Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies

  2006cited by this paper
• Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women

  2006cited by this paper
• Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

  2006cited by this paper
• Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical

  2002cited by this paper
• Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women

  2002cited by this paper
• A multivariate technique for multiply imputing missing values using a sequence of regression models

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Differentiation and breast cancer.

  1997cited by this paper
• Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

  1997cited by this paper
• Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?

  1995cited by this paper
• Reproductive factors and breast cancer.

  1993cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper

• Long Intergenic Non-Coding RNA 00511 (LINC00511) Genetic Variations and Haplotypes in Breast Cancer: A Case-Controlled Study and Bioinformatics Analysis

  2025cites this paper
• Global determinants of breast cancer mortality: a comprehensive meta-analysis of clinical, demographic, and lifestyle risk factors

  2025cites this paper
• Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study

  2024cites this paper
• Assessing the effect of childbearing on blood DNA methylation through comparison of parous and nulliparous females

  2024cites this paper
• Advance in the application of MOF composites for breast cancer biomarkers sensing detection

  2024cites this paper
• Application of Novel Breast Biospecimen Cell-Type Adjustment Identifies Shared DNA Methylation Alterations in Breast Tissue and Milk with Breast Cancer–Risk Factors

  2023cites this paper
• Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis

  2023cites this paper
• Physical activity from menarche-to-first pregnancy and risk of breast cancer: the California teachers study

  2022cites this paper
• Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors

  2021cites this paper
• Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

  2021cites this paper
• Parity and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis.

  2021cites this paper
• Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.

  2020cites this paper
• Reproductive factors and risk of breast cancer : a pooled meta-analysis of 55 case-control studies based on different source populations

  2019cites this paper
• Apoptotic Index Fails to Predict Chemoresponse in Breast Cancer

  2019cites this paper
• Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?

  2019cites this paper
• Molecular Subtypes of Breast Carcinoma in South Indian Women and their Correlation with Histomorphological and Clinical Features

  2019cites this paper
• Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study

  2019cites this paper
• Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression

  2019cites this paper
• Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.

  2019cites this paper
• Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer

  2019cites this paper
• Factors influencing diagnosis and outcome in HER2 receptor positive breast cancer

  2019cites this paper
• Breast Cancer Risk Factors and Associations with Breast Cancer Tumor Characteristics in High Risk Populations

  2018influential citation
• The Relationship of Reproductive Risk Factors and Histologic Patterns with Molecular Subtypes of Breast Cancer

  2018cites this paper
• Reproductive history, breast‐feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study

  2018cites this paper
• Relationship Between ADAMTS8, ADAMTS18, and ADAMTS20 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Expressions and Tumor Molecular Classification, Clinical Pathological Parameters, and Prognosis in Breast Invasive Ductal Carcinoma

  2018cites this paper
• Molecular genetics of lobular breast cancer ductal carcinoma in situ

  2018cites this paper
• Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer

  2018cites this paper
• Over-using chemotherapy in the adjuvant setting.

  2017cites this paper
• Background Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI: Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer.

  2017cites this paper
• Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI : Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer

  2017cites this paper
• Effect of comprehensive nursing intervention on therapy and life quality of patients with breast cancer

  2017cites this paper
• Correlation of Histopathological Features and Immunohistochemistry in the study of Breast Cancer

  2017cites this paper
• Caspase 3 as Prognostic Marker for Triple Negative Breast Cancer Chemotherapy

  2017cites this paper
• Breast MRI background parenchymal enhancement: a potential bridge to molecular cancer subtype?

  2017cites this paper
• Reproductive Issues in Breast Cancer

  2016cites this paper
• Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype

  2016cites this paper
• Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway

  2016cites this paper
• Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study

  2016cites this paper
• Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies

  2016cites this paper
• Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women

  2016cites this paper
• Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.

  2016cites this paper
• Determinants of Advanced Stage at Initial Diagnosis of Breast Cancer in Pakistan: Adverse Tumor Biology vs Delay in Diagnosis.

  2016cites this paper
• Effect of Reproductive, Menstrual and Familial Factors on The risk of Breast Cancer pre and post Menopause

  2016cites this paper
• Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.

  2016influential citation
• Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies.

  2015cites this paper
• Disparities in Breast Cancer and African Ancestry: A Global Perspective

  2015cites this paper
• Established breast cancer risk factors and risk of intrinsic tumor subtypes.

  2015cites this paper
• The correlationship of Ki-67 with clinical pathological characteristics and efficacy of neoadjuvant chemotherapy in breast cancer

  2015cites this paper
• Dietary and Reproductive Risk Factors for Breast Cancer in the Nurses' Health Studies

  2015cites this paper
• The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas

  2015cites this paper
• Adjuvant chemotherapy may improve survival of patients with luminal A breast cancer and positive lymph nodes.

  2015cites this paper
• Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer

  2015cites this paper
• Mechanisms of Action of Metformin as an Anti-cancer Agent

  2014cites this paper
• Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility

  2014cites this paper
• Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor Characteristics

  2014cites this paper
• Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer

  2014cites this paper
• Successes and limitations of targeted cancer therapy in breast cancer.

  2014cites this paper
• Reproductive risk factors and breast cancer subtypes: a review of the literature

  2014cites this paper
• Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women

  2014influential citation
• Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.

  2014cites this paper
• Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies

  2014cites this paper
• Luminal (Her2 negative) prognostic index and survival of breast cancer patients.

  2014cites this paper
• Can Molecular Subtyping Replace Axillary Nodal Status as Prognostic Marker in Breast Cancer?

  2014cites this paper
• Optimal adjuvant chemotherapy in breast cancer: selection of agents

  2014cites this paper
• p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis

  2014cites this paper
• Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status

  2014cites this paper
• Competing risks in low-risk breast cancer.

  2013cites this paper
• Association between mammographic density and basal-like and luminal A breast cancer subtypes

  2013cites this paper
• Association of immunohistochemically defined molecular subtypes with clinical response to presurgical chemotherapy in patients with advanced breast cancer.

  2013cites this paper
• Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.

  2013cites this paper
• Mammographic density, MRI background parenchymal enhancement and breast cancer risk.

  2013cites this paper
• Reproductive Factors, Heterogeneity, and Breast Tumor Subtypes in Women of Mexican Descent

  2013cites this paper
• Androgen receptor in triple negative breast cancer.

  2013cites this paper
• СОВРЕМЕННЫЕ ПОДХОДЫ К ЛЕЧЕНИЮ БОЛЬНЫХ ПЕРВИЧНО- ОПЕРАБЕЛЬНЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ

  2013cites this paper
• Epidemiology of Breast Cancer in Women.

  2013cites this paper
• The challenge to reduce breast cancer mortality in Okinawa: consensus of the first Okinawa breast oncology meeting.

  2013cites this paper
• Current approaches to the treatment of patients with primary resectable breast cancer

  2013cites this paper
• Breast Cancer Subtypes and Previously Established Genetic Risk Factors: A Bayesian Approach

  2013cites this paper
• New drugs for breast cancer subtypes: targeting driver pathways to overcome resistance.

  2012cites this paper
• Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry

  2012cites this paper
• Hypothesized role of pregnancy hormones on HER2+ breast tumor development

  2012cites this paper
• PHYSICAL ACTIVITY ACROSS THE LIFE COURSE AND RISK OF PRE- AND POST-MENOPAUSAL BREAST CANCER

  2012cites this paper
• Is adjuvant chemotherapy useful for women with luminal a breast cancer?

  2012cites this paper
• Risk Factors for Uncommon Breast Cancer Histologic Types

  2012cites this paper
• Targeting the subtypes of breast cancer: rethinking investigational drugs

  2012cites this paper
• Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.

  2012cites this paper
• PREGNANCY AND ITS ASSOCIATION WITH BREAST CANCER TUMOR SUBTYPES

  2011cites this paper
• Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.

  2011cites this paper
• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

  2011cites this paper
• BREAST CANCER TRENDS AMONG KENTUCKY WOMEN, 2004-2007

  2011cites this paper
• Epidemiology of triple negative breast cancers.

  2010influential citation